Physician profile
Jonathan A Dean
NPI 1952545444
$4,084.82
in general payments reported to CMS, 2019-2025
34 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $466 · 2021: $640 · 2022: $681 · 2023: $625 · 2024: $357 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $828.71 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $481.76 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $339.89 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $281.29 | 2019-2024 | Xifaxan, Trulance |
| Allergan, INC. | $252.31 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $246.52 | 2019-2022 | |
| Lilly USA, LLC | $174.75 | 2019-2023 | Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $157.44 | 2021-2023 | |
| Pfizer INC. | $132.46 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $114.75 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $112.32 | 2023-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $110.25 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.47 | 2019-2020 | |
| Glaxosmithkline, LLC. | $92.05 | 2019-2024 | Trelegy Ellipta |
| Amgen INC. | $81.26 | 2019-2025 | Repatha, Otezla |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $72.82 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ucb, INC. | $53.27 | 2019 | |
| Boston Scientific Corporation | $52.76 | 2025 | Watchman Access System |
| Phathom Pharmaceuticals, INC. | $49.01 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $47.35 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.02 | 2025 | Caplyta |
| Genentech USA, INC. | $35.81 | 2021 | |
| Eisai INC. | $32.61 | 2020 | |
| Axsome Therapeutics, INC. | $28.44 | 2024 | Auvelity |
| Merck Sharp & Dohme LLC | $27.50 | 2019 | |
| Mylan Specialty L.P. | $27.27 | 2021-2024 | Yupelri |
| Astellas Pharma US INC | $18.26 | 2019 | |
| Adlon Therapeutics L.P. | $15.40 | 2020 | |
| Resmed Corp | $14.55 | 2023 | |
| Currax Pharmaceuticals LLC | $14.04 | 2020 | |
| Ironwood Pharmaceuticals, INC | $13.29 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.57 | 2019 | |
| Inogen, INC. | $11.38 | 2022 | |
| Vifor Pharma, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.